MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

DEXA Predicts Diabetes in Obese Menopausal Women

By MedImaging International staff writers
Posted on 13 Sep 2021
Print article
Image: Bone density measurements can also help diagnose diabetes in older women (Photo courtesy of Alamy)
Image: Bone density measurements can also help diagnose diabetes in older women (Photo courtesy of Alamy)
Dual-energy x-ray absorptiometry (DEXA) beats traditional clinical obesity measures for predicting diabetes and heart disease in older women, according to a new study.

Researchers at Stanford University (CA, USA), the University of Illinois in Chicago (UIC; USA), and other institutions analyzed data on 9,744 postmenopausal women (50-79 years of age) who underwent a DEXA scan and were free of cardiovascular disease (CVD) and diabetes at baseline. The aim of the study was to see if DEXA estimates of adiposity in older women could improve risk prediction for cardiometabolic diseases better than the traditional surrogates - body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR).

The results revealed a total of 1,327 diabetes, 1,266 atherosclerotic CVD, and 292 heart failure (HF) cases, as well as 1,811 deaths from any cause accrued during a median follow-up of 17.2 years. The largest hazard ratio per adiposity measure for diabetes and atherosclerotic CVD was percentage of trunk fat (%TrF), which was also the only adiposity measure to demonstrate statistically significant improved concordance probability estimates over BMI, WC, and WHR. The study was published on August 31, 2021, in Mayo Clinic Proceedings.

“The single most striking finding of our multivariable analyses was the magnitude of association observed between %TrF and the risk of incident diabetes,” concluded lead author Deepika Laddu, PhD, of the University of Chicago. “Using DEXA to improve risk prediction for cardiometabolic diseases among patients already being screened for osteoporosis presumably would have little impact on cost of care, and has the potential to impact public health substantially.”

DEXA is a means of measuring bone mineral density (BMD) using spectral imaging. Two X-ray beams, with different energy levels, are aimed at the bones. When soft tissue absorption is subtracted, BMD can be determined from the absorption of each beam. DEXA is most often used to diagnose and monitor osteoporosis.

Related Links:
Stanford University
University of Illinois in Chicago


Mobile Cath Lab
Photon F65/F80
3T MRI Scanner
MAGNETOM Cima.X
Portable Color Doppler Ultrasound Scanner
DCU10
X-Ray Illuminator
X-Ray Viewbox Illuminators

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more